Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. However, to date there is limited evidence on how to monitor patients with asthma. Childhood asthma introduces specific challenges in terms of deciding what, when, how often, by whom and in whom different assessments of asthma should be performed. The age of the child, the fluctuating course of asthma severity, variability in clinical presentation, exacerbations, comorbidities, socioeconomic and psychosocial factors, and environmental exposures may all influence disease activity and, hence, monitoring strategies. These factors will be addressed in herein. We identified large knowledge gaps in the effects of different monitoring strategies in children with asthma. Studies into monitoring strategies are urgently needed, preferably in collaborative paediatric studies across countries and healthcare systems.

Original publication

DOI

10.1183/16000617.00003714

Type

Journal article

Journal

Eur Respir Rev

Publication Date

06/2015

Volume

24

Pages

178 - 186

Keywords

Age Factors, Anti-Asthmatic Agents, Asthma, Child, Child, Preschool, Decision Support Techniques, Disease Progression, Evidence-Based Medicine, Humans, Infant, Lung, Practice Guidelines as Topic, Predictive Value of Tests, Respiratory Function Tests, Risk Factors, Severity of Illness Index, Time Factors, Treatment Outcome